Fluticasone propionate 250 mcg

DRUG3 trials

Sponsors

Novartis Pharmaceuticals, GlaxoSmithKline

Conditions

AsthmaPersistent Asthma

Phase 3

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

CompletedNCT02094937

GlaxoSmithKlineAsthma

Start: 2014-03-27End: 2015-08-28Updated: 2017-05-25

Phase 4

Study of Safety of Foradil in Patients With Persistent Asthma

TerminatedNCT01845025

Novartis PharmaceuticalsPersistent Asthma

Start: 2013-05-31End: 2016-05-31Updated: 2017-03-21

Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)

CompletedNCT02730351

GlaxoSmithKlineAsthma

Start: 2016-05-25End: 2017-02-03Updated: 2019-07-16